APA (7th ed.) Citation

Urbanska, E. M., Grauslund, M., Koffeldt, P. R., Truelsen, S. L. B., Löfgren, J. O., Costa, J. C., . . . Santoni-Rugiu, E. (2023). Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR -Mutated NSCLC. International Journal of Molecular Sciences, 24(17), 13077. https://doi.org/10.3390/ijms241713077

Chicago Style (17th ed.) Citation

Urbanska, Edyta M., Morten Grauslund, Peter R. Koffeldt, Sarah L. B. Truelsen, Johan O. Löfgren, Junia C. Costa, Linea C. Melchior, Jens B. Sørensen, and Eric Santoni-Rugiu. "Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR -Mutated NSCLC." International Journal of Molecular Sciences 24, no. 17 (2023): 13077. https://doi.org/10.3390/ijms241713077.

MLA (9th ed.) Citation

Urbanska, Edyta M., et al. "Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR -Mutated NSCLC." International Journal of Molecular Sciences, vol. 24, no. 17, 2023, p. 13077, https://doi.org/10.3390/ijms241713077.